[Antitumor action of berberinol thiophosphamide in experimental tumors in mice].
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D007279:Injections, Subcutaneous; D008223:Lymphoma / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012510:Sarcoma 180 / Q000188:drug therapy; D012511:Sarcoma 37 / Q000188:drug therapy; D013852:Thiotepa / Q000008:administration & dosage / Q000494:pharmacology*
D013852:Thiotepa
Protivoopukholevoe deĭstvie berberinol-tiofosfonida pri éksperimental'nykh opukholiakh u mysheĭ